(Banner graphic of PRSA 2017 Health Academy Conference logo)

PRSA 2017 Health Academy Conference

May 26–28 | Grand Floridian Resort & Spa, Orlando

Check out Pre-Conference Co-Chair and Bliss Integrated Communications Health Care Leader Michael Roth's ComPRehension blog post, “Eli Lilly, Novartis, FDA, the National Health Council and Top Advocacy Groups Discuss Tectonic Shifts in Patient Communications.”  

Wednesday, May 7
1–5 p.m.
Pre-Conference Session*
Kaiser Permanente Center for Total Health
700 2nd Street NE, Washington, D.C. 20002
Transportation will leave from the lobby of the Marriott Hotel at 12:30 p.m.

This is an optional ticketed event not included in the basic conference fee.

“Patient-Centric Communications: How the FDA and Advocacy Groups Are Rewriting the Health Care PR Playbook”

Tectonic shifts in the health care landscape are propelling patients to the center of a complex web of decision-making that involves choices in practically every aspect of their care, including treatment options, choice of providers, and the development of pharmaceuticals. Among the many mandatory and best-practice provisions to guide patient involvement, public relations professionals need to understand how these changes will impact their work, and how to best advise patient groups to navigate patient communications and content distribution in the modern era.

Our pre-conference program provides an in-depth look at how the patient’s perspective is changing health care marketing and communications in new and exciting ways. The two-part program brings together senior executives from government, industry, patient advocacy and the media to provide informative and useful insights for communications professionals who are learning to communicate with and engage patients and their families.

Introduction and Opening Remarks: 
Michael Roth, Session Co-Chair and Head of Healthcare, Bliss Integrated Communications 

Our first panel, “Why Patients Matter Now, More Than Ever” provides attendees with a firsthand look at the FDA Patient Focused Drug Development initiative, which places patients in a central role within the clinical development and regulatory framework.

Moderator: Michele Oshman, director, federal advocacy relations, Eli Lilly & Company

Panelists:  Sara Eggers, PhD, senior economist, Office of Planning and Informatics,
     Center for Drug Evaluation and Research, U.S. Food and Drug Administration
      Eric Gascho, assistant vice president, Government Affairs, National Health Council
      Pat Furlong, founding president and CEO, Parent Project for Muscular Dystrophy 

Our second panel, “Winning Communications Strategies for Patient Advocacy Organizations” will showcase successful case studies of patient communications campaigns and partnerships from the field, featuring strategies and tactics that provide insights into impactful media programs in the new patient landscape.

Moderator: Tracy Furey, vice president, public affairs and communications, Novartis Oncology North America

• Mary Dunkle, vice president of communications, National Organization for Rare Disorders (NORD)
• Linda House, RN, executive vice president for external affairs, Cancer Support Community
• Scott Riccio, vice president, advocacy and external affairs, The Leukemia & Lymphoma Society
• Louise Vetter, chief executive officer, Huntington’s Disease Society of America 

This special pre-conference was made possible by a generous sponsorship by Bliss Integrated Communications, NYC and the PRSA Health Academy.

Register now!